1. J. W. Black, W. A. M. Duncan, C. J. Durant, C. R. Ganellin and E. M. Parsons,Definition and antagonism of histamine H 2-receptors. Nature236, 385–390 (1972).
2. R. W. Brimblecombe, W. A. M. Duncan, C. J. Durant, J. C. Emmet, C. R. Ganellin and E. M. Parsons,Cimetidine — A non-thiourea H 2 receptor antagonist. J. Med. Res.3, 86–92 (1975).
3. M. Takeda, T. Takagi, Y. Yashima and H. Maeno,Effect of a new potent H 2-eblocker, 3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats. Drug Res.32, 734–737 (1982).
4. J. Bradshaw, R. T. Brittain, M. J. Clitherow, D. Daly, D. Jack, B. J. Price and R. Stable,Ranitidine a new potent selective H 2-receptor antagonist. Br. J. Pharmacol.66, 464 (1979).
5. G. Bertaccini, G. Coruzzi, E. Poli and M. Adami,Pharmacology of the novel H 2 antagonist famotidine: in vitro studies. Agents and Actions19, 180–187 (1986).